Autoimmune Complications in Chronic Lymphocytic Leukemia (CLL)

由 Zent, Clive S., Kay, Neil E.
出版 2010

The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia

由 Nabhan, Chadi, Kay, Neil E.
出版 2011

Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach

由 ZENT, CLIVE S., KAY, NEIL E.
出版 2011

Familial CLL: What Does It Mean to Me?

由 Slager, Susan L., Kay, Neil E.
出版 2009

Critical Signal Transduction Pathways in CLL

由 Ghosh, Asish K., Kay, Neil E.
出版 2013

Neuropilin-1 is expressed by chronic lymphocytic leukemia B cells

由 Nowakowski, Grzegorz S., Mukhopadhyay, Debabrata, Wu, Xiaosheng, Kay, Neil E.
出版 2008

How we treat Richter syndrome

由 Parikh, Sameer A., Kay, Neil E., Shanafelt, Tait D.
出版 2014

A NOVEL METHOD FOR ANALYSIS OF HUMAN T CELL REPERTOIRES BY REAL-TIME PCR

由 Wettstein, Peter J., Borson, Nancy D., Kay, Neil E.
出版 2014

Microvesicles in CLL: predictor of disease progression/relapse

由 Maiti, Guru P., Kay, Neil E., Ghosh, Asish K.
發表在 Oncotarget (2017)

Chronic lymphocytic leukemia in 2020: a surfeit of riches?

由 Parikh, Sameer A., Gale, Robert Peter, Kay, Neil E.
發表在 Leukemia (2020)

Quantitative Protein Expression Analysis Of CLL B Cells from Mutated and Unmutated IgV(H) Subgroups Using Acid-Cleavable Isotope-Coded Affinity Tag Reagents

由 Barnidge, David R., Jelinek, Diane F., Muddiman, David C., Kay, Neil E.
出版 2005

Curcumin Inhibits Pro-survival Pathways in CLL B-cells and has the Potential to Overcome Stromal Protection of CLL B-cells in Combination with EGCG

由 Ghosh, Asish K., Kay, Neil E., Secreto, Charla R., Shanafelt, Tait D.
出版 2009

Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia

由 Tschumper, Renee C., Shanafelt, Tait D., Kay, Neil E., Jelinek, Diane F.
發表在 Oncotarget (2019)

N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia

由 KAY, NEIL E., SHANAFELT, TAIT D., CALL, TIMOTHY G., WU, WENTING, LAPLANT, BETSY R.
出版 2009

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells...

由 Ougolkov, Andrei V., Bone, Nancy D., Fernandez-Zapico, Martin E., Kay, Neil E., Billadeau, Daniel D.
出版 2007

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression

由 Ghosh, Asish K., Secreto, Charla R., Knox, Traci R., Ding, Wei, Mukhopadhyay, Debabrata, Kay, Neil E.
出版 2010

Differentiation of Chronic Lymphocytic Leukemia B Cells into Immunoglobulin Secreting Cells Decreases LEF-1 Expression

由 Gutierrez, Albert, Arendt, Bonnie K., Tschumper, Renee C., Kay, Neil E., Zent, Clive S., Jelinek, Diane F.
出版 2011

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group()

由 Lacy, Martha Q., Jacobus, Susanna, Blood, Emily A., Kay, Neil E., Rajkumar, S. Vincent, Greipp, Philip R.
出版 2009

Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch”

由 Kay, Neil E., Shanafelt, Tait D., Strege, Ann K., Lee, Yean K., Bone, Nancy D., Raza, Azra
出版 2007

The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy

由 Ghosh, Asish K., Secreto, Charla, Boysen, Justin, Sassoon, Traci, Shanafelt, Tait D., Mukhopadhyay, Debabrata, Kay, Neil E.
出版 2011